MedicaidCoverageMedium impact
HASA 22-02
Michigan Medicaid - MDHHS·MI · Pharmacy, Infectious Disease·Provider Bulletin
Effective date
Feb 18, 2022
We identified it
Jun 20, 2026
Summary
Michigan Medicaid will now reimburse pharmacy providers for administering FDA Emergency Use Authorization COVID-19 monoclonal antibody subcutaneous injections. Pharmacies must enroll through the same process as COVID-19 vaccine providers and can bill administration at 100% of Medicare rates during the Public Health Emergency.
Action Required
Immediately: Michigan Medicaid-enrolled pharmacy providers must complete COVID-19 vaccine enrollment process to administer monoclonal antibody injections. Bill drug products at $0.00 when federally supplied. Document medical necessity and EUA compliance for all administrations. Reference billing instructions at michigan.magellanrx.com/provider and CHAMPS system for specific rates.